Exercise capacity and cytochrome oxidase activity in muscle mitochondria of COPD patients

Respiratory Medicine

Volumn 104, Issue 1, 2010, Pages 83-90

  D'Agostino, Bruno ^a   Polverino, Mario ^b   Cirino, Giuseppe ^c   Lombardi, Assunta ^c   Grassi, Bruno ^d   Sullo, Nikol ^a   Santoriello, Carlo ^b   Polverino, Francesca ^b   Orlotti, Donatella ^a   Matteis, Maria ^a   Rossi, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Cava de' Tirreni Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic obtructive pulmonary disease; Cytochrome oxidase activity; Long acting agonists; Skeletal muscle dysfunction

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOCHROME C OXIDASE; FORMOTEROL; PLACEBO; TAU PROTEIN;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY YIELD; ERGOMETRY; EXERCISE; HUMAN; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

AGED; BRONCHODILATOR AGENTS; ELECTRON TRANSPORT COMPLEX IV; ETHANOLAMINES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OXIDATIVE STRESS; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SINGLE-BLIND METHOD;

EID: 73849146815     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.07.016     Document Type: Article

References (35)

1. Sin D.D., and Man S.F. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2 (2005) 8-11
2. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353 (1999) 1649-1652
3. Bolton C.E., Ionescu A.A., Shiels K.M., et al. Associated loss of fat free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 1286-1293
4. Agustí A.G., Noguera A., Sauleda J., et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 347-360
5. Mostert R., Goris A., Weling-Scheepers C., et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 94 (2000) 859-867
6. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159 (1999) S1-S40
7. Reid M.B. COPD as a muscle disease. Am J Respir Crit Care Med 164 (2001) 1101-1102
8. Debigare R., Cote C.H., and Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 164 (2001) 1712-1717
9. Sauleda J., Garcia-Palmer F., Wiesner R.J., et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1413-1417
10. Maltais F., LeBlanc P., Whittom F., et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55 (2000) 848-853
11. Agusti A.G., Sauleda J., Miralles C., et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 485-489
12. Degens H., Swisher A.K., Heijdra Y.F., et al. Apoptosis and Id2 expression in diaphragm and soleus muscle from the emphysematous hamster. Am J Physiol Regul Integr Comp Physiol 293 (2007) R135-R144
13. Orozco-Levi M., Lloreta J., Minguella J., et al. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1734-1739
14. Grassino A., Hayot M., and Czaika G. [Biology of muscle injury and repair]. Arch Bronconeumol 36 (2000) 344-350
15. Wende A.R., Huss J.M., Schaeffer P.J., and Giguere V. Kelly DP PGC-1α coactivates PDK4 gene expression via the orphan nuclear receptor ERR α: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 25 (2005) 10684-10694
16. 2-adrenergic agonists. Cancer Res 67 13 (2007)
17. Balanag V.M., Yunus F., Yang P.C., et al. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 19 (2006) 139-147
18. Aalbers R., Ayres J., Backer V., et al. Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J 19 (2002) 936-943
19. Liesker J.J., Van De Velde V., Meysman M., et al. Effects of formoterol (oxis turbuhaler) and ipratropium on exercise capacity in patients with COPD. Respir Med 96 (2002) 559-566
20. Celli B.R., MacNee W., and ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 6 (2004) 932-946
21. Celli B.R., Cote G.C., Marin J.M., et al. Airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
22. Aulie A., and Grav H.J. Effect of cold acclimation on the oxidative capacity of skeletal muscles and liver in young bantam chicks. Comp Biochem Physiol 62A (1979) 335-338
23. ATS/ACCP. Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167 (2003) 211-277
24. Oga T., Nishimura K., Tsukino M., et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 161 (2000) 1897-1901
25. Man W.D., Mustfa N., Nikoletou D., et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 59 (2004) 471-476
26. O'Donnell D.E., Voduc N., Fitzpatrick M., et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 86-94
27. Jansky L. Total cytochrome oxidase activity and its relation to basal and maximal metabolism. Nature 189 (1961) 921-922
28. Radom-Aizik S., Kaminski N., Hayek S., Halkin H., Cooper D.M., and Ben-Dov I. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol 102 5 (2007 May) 1976-1984
29. Miura S., Kawanaka K., Kai Y., et al. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated by β-adrenergic receptor activation. Endocrinology 148 7 (2007) 3441-3448
30. Mottillo E.P., Shen X.J., and Granneman J.G. Role of hormone-sensitive lipase in beta-adrenergic remodelling of white adipose tissue. Am J Physiol Endocrinol Metab 293 5 (2007) E1188-E1197
31. Ribera F., N'Guessan B., Zoll J., et al. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 6 (2003) 873-879
32. Lecaillon J.B., Kaiser G., Palmisano M., et al. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of foradil dry powder inhalation via aerolizer. Eur J Clin Pharmacol 55 2 (1999) 131-138
33. Derks M.G., van den Berg B.T., van der Zee J.S., et al. Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions. J Pharmacol Exp Ther 283 2 (1997) 824-832
34. 2-agonists and corticosteroids. FASEB J 15 (2001) 261-269
35. Lancaster Jr. J.R., Laster S.M., and Gooding L.R. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor. FEBS Lett 248 1-2 (1989) 169-174